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Infectious Disease Epidemiology Report 
Invasive Methicillin-Resistant Staphylococcus aureus (MRSA) 
Maine, 2012 
  
 
 
Background 
Staphylococcus aureus, often referred to as "staph," are 
bacteria commonly found on the skin or in the nose of 
25 - 30% of the U.S. population. This organism is called 
Methicillin-sensitive Staphylococcus aureus (MSSA). 
Most of the time, staph do not cause any harm. 
Methicillin-resistant Staphylococcus aureus (MRSA) is 
a type of staph that is resistant to certain antibiotics 
called beta-lactams. These antibiotics include methicillin 
and other more common antibiotics such as penicillin, 
amoxicillin, and oxacillin. Less than 2% of people in the 
U.S. are colonized with MRSA.  
Severe or potentially life-threatening MRSA infections 
occur most frequently among patients in healthcare 
settings with an invasive MRSA infection. Patients in 
healthcare facilities may have weakened immune 
systems, undergo procedures (such as surgery) or have 
catheters inserted into the skin. These conditions make it 
easier for MRSA to get into the body and infect sterile 
sites, such as blood.  
 
Methods 
An invasive MRSA infection is defined as MRSA 
isolated from a normally sterile site (blood, 
cerebrospinal fluid, pleural fluid, etc.). Common 
invasive MRSA infections include bloodstream 
infections and joint infections. Symptoms vary by 
infection location. Invasive MRSA infections are a 
reportable condition in Maine.  
 
Results 
During 2012, a total of 114 confirmed cases of invasive 
MRSA infections were reported to Maine CDC. This is a 
slight decrease from the 121 cases reported in 2011. The 
rate of invasive MRSA infections in Maine was 8.6 
cases per 100,000 persons (Figure 1). Reporting of 
invasive MRSA infections started in April 2008; 
therefore, data for 2008 do not represent a full year. This  
may account for the low rate of reported invasive MRSA 
infections in 2008.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Invasive MRSA Infection Rates in Maine, 2008-2012 
 
Fifty-eight percent of invasive MRSA infections 
reported in Maine were among males. The median age 
among reported invasive MRSA infections was 66 years 
(range 1 month to 93 years).  
 
Figure 2: Invasive MRSA Infections by Age in Maine, 2012 
 
 
During 2012, invasive MRSA infections were reported 
in residents from all 16 counties in Maine (Figure 3). 
The rate of invasive MRSA infections was highest in 
Aroostook County (24.0 cases per 100,000 residents).   
Eight counties had rates of invasive MRSA higher than 
the state rate (Aroostook, Cumberland, Kennebec, 
Lincoln, Oxford, Piscataquis, Somerset and Waldo). 
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Figure 3: Rate of Invasive MRSA Infections by County of 
Residence in Maine, 2012 
 
 
Discussion 
Maine CDC began routine surveillance for invasive 
MRSA infections in 2008 when it was added to the 
Maine CDC Notifiable Conditions List. Maine 
surveillance data for 2012 indicate the rate of invasive 
MRSA infections has decreased slightly.  
 
Although non-invasive MRSA is not reportable, the best 
way to prevent invasive MRSA is to prevent non-
invasive MRSA including skin and soft tissue infections. 
 
The most significant risk factor for MRSA infection is 
open wounds or broken skin, such as a surgical site. 
However, MRSA infections can occur on areas of the 
skin where there is no obvious wound or break in the 
skin. 
 
Preventive measures to reduce MRSA transmission: 
• Cover wounds with clean, dry bandages until 
healed 
• Do not attempt to treat a MRSA skin infection 
by yourself; doing so could worsen or spread it 
to others 
• Wash hands with soap and water or use an 
alcohol-based hand rub to prevent the spread of 
MRSA 
• Use disinfectants effective against 
Staphylococcus aureus 
• Avoid sharing personal items including towels, 
washcloths, razors, and clothing 
• Avoid contact sports and other skin-to-skin 
contact until your infection has healed 
 
Invasive MRSA infections and all outbreaks of MRSA 
are reportable to Maine CDC by calling 1-800-821-5821 
or faxing to 1-800-293-7534. MRSA infections that are 
acquired from a healthcare facility are reportable to the 
National Healthcare Safety Network, a federal CDC 
surveillance system. For more information contact your 
healthcare provider.   
 
Additional information about MRSA infections is 
available at: 
• Maine CDC website: 
http://www.maine.gov/dhhs/mecdc/infectious-
disease/epi/airborne/mrsa.shtml 
• Federal CDC website: http://www.cdc.gov/mrsa/ 
• Prevention of MRSA Infections: 
http://www.cdc.gov/mrsa/prevent/index.html 
 
